Keith Wittstock

Statistics

Publications

Citations

H-Index

Active since

2021

Affiliations

Bristol-Myers Squibb (United States)(Current)

University of Massachusetts Chan Medical School

Navitas Systems (United States)

Keith Wittstock is an author at Bristol-Myers Squibb (United States) specializing in pharmacotherapy, rheumatoid arthritis pharmacotherapy, and immunotherapy.

ORCID

Publications per year

2021–2024

Publications

Baseline Anti-Citrullinated Protein Antibody Status and Response to Abatacept or Non-TNFi Biologic/Targeted-Synthetic DMARDs: US Observational Study of Patients with RA

Leslie R. Harrold, Seán Connolly, Keith Wittstock et al. · Rheumatology and Therapy · 2021 · 21 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Disparities in burden of disease in patients with rheumatoid arthritis across racial and ethnic groups

Jacqueline O’Brien, Sang Hee Park, Taylor Blachley et al. · Clinical Rheumatology · 2024 · 10 citations · Full text

Public Health, Health Sciences, Epidemiologic Methods +16

1–2 of 2